Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The first interleukin-6 (il-6) receptor antagonist has been approved for the treatment of rheumatoid arthritis (RA).

Tocilizumab Injection (Actemra®)